Sandoz Sets New Rules for Use of Clozaril

OPEN MINDS The Behavioral Health & Social Service Industry Analyst Industry News Sandoz Pharmaceuticals Corporation announced a new set of rules for doctors, hospitals, and pharmacists to devise their own patient blood monitoring systems to facilitate the use of Clozaril. Since Clozaril came on the market in February, 1990, it has been available only along with Sandoz’s proprietary Clozaril Patient Monitoring System, under which patients undergo weekly blood tests as a condition for getting a weekly supply of the medication. Under the new system, Sandoz will require doctors and pharmacists to form their own groups to provide both the . . .